Skip to Main Content
Professional Photo

Hunter Threet


Hunter Threet is an associate in Nashville and a member of the Corporate Group.

Professional Biography

Mr. Threet regularly represents venture capital funds, family offices, and angel investors in connection with structuring, documenting, and closing growth investments. He also serves as outside counsel to several emerging growth companies in the health care and technology industries and advises such companies on a wide range of business issues, including their day-to-day commercial contracts, debt financings, and intellectual property protection. Mr. Threet has significant experience advising strategic and financial buyers and sellers in mergers, acquisitions, and other liquidity transactions.

  • Represented Martin Ventures where Martin Ventures was lead investor or co-investor in the purchase of debt and equity securities for the following companies:

    • ReadiVet, an on-demand veterinary care company.
    • Reimagine Care, Inc., a company that partners with health care systems and independent oncologists to support value-based oncology care delivery in the community setting.
    • StationMD, a telehealth medical service that offers immediate virtual access to board-certified physicians specifically trained in the care of people with intellectual and developmental disabilities.
  • Represented Mountain Group Partners where Mountain Group was lead investor in the purchase of debt and equity securities for the following companies:

    • Airvet, a company that offers virtual pet telehealth to large and mid-sized enterprises as an employee benefit.
    • AngelEye Health, Inc., a company that has developed internet-based camera systems and educational and clinical communications software to transform neonatal care.
    • Circular Genomics, a leader in the use of circular RNA as a novel biomarker to power precision medicine to improve the diagnosis and treatment of neurological and psychiatric conditions.
    • In the Bowl Animal Health, Inc., a company that provides pet owners with a creative alternative to current methods of drug administration.
    • Mindera Health, Inc., a company that has developed a proprietary micro biopsy tool.
    • TARGAN, Inc., a poultry vaccine delivery device company.
    • Verility, a company that offers a mobile based testing platform for fertility analysis in swine and other farm animals.
    • Vytelle, a company developing in vitro fertilization and data technologies for improved cattle genetics and performance.
  • Represented a Nashville-based health care venture capital fund, which serves as a lead investor in Series Seed and Series A Preferred Stock financing rounds conducted by health care technology companies.

  • Represented an Atlanta-based venture capital fund, which serves as the lead investor in Series Seed and Pre-Series Seed financing rounds conducted by technology companies.

  • Represented a Nashville-based family office in connection with its investment in a California-based technology company focused on providing water management solutions to farmers in the western part of the United States and its initial investment (and the realization of such investment) in a European data analytics company.

  • Represented a D.C.-based family office in connection with its investment in several growth companies.

  • Represented a software-as-a-service (SaaS) provider in the $23 million sale of all its capital stock to a private equity buyer.

  • Listed in Best Lawyers: Ones to Watch in America™ for Corporate Law and Securities Regulation (2024)


  • The University of Tennessee College of Law, J.D., 2017, summa cum laude
    • Tennessee Law Review, research editor
    • Order of the Coif
  • The University of Tennessee, B.A., 2014, summa cum laude


  • Tennessee

Email Disclaimer

NOTICE: The mailing of this email is not intended to create, and receipt of it does not constitute an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.
Cancel Accept